| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |